Sanofi
SNYNASDAQHealthcare● Active
$43.88
$-1.14(-2.53%)
Market Cap$105.7B
P/E Ratio—
52W High$52.68
52W Low$42.28
Sanofi（SNY）· 现金流量表
年度 / 季度 / TTM 视图 · SEC 10-K 与 10-Q（经 FMP 聚合）· 可在下方切换周期与 M/B/T 单位。
FMP · SNY · 截至 2026-06-10
财务报表
Operating CF · CapEx · Free Cash Flow
| Breakdown | 2025-12 | 2024-12 | 2023-12 | 2022-12 | 2021-12 |
|---|---|---|---|---|---|
| Operating Activities | |||||
| Net Income | $5.57B | $5.50B | $5.40B | $8.37B | $6.22B |
| Depreciation & Amort. | $6.46B | $3.59B | $3.78B | $3.42B | $3.35B |
| Stock-Based Comp. | $0.00B | $0.00B | $0.00B | $0.24B | $0.24B |
| Change in Working Capital | $2.03B | ($0.61B) | $0.76B | ($0.71B) | $1.41B |
| Net Cash from Operations | $12.13B | $9.08B | $10.26B | $10.53B | $10.52B |
| Investing Activities | |||||
| Capital Expenditure | ($1.99B) | ($3.19B) | ($1.62B) | ($2.20B) | ($2.04B) |
| Purchases of Investments | ($11.37B) | $0.00B | ($0.13B) | ($0.49B) | ($0.31B) |
| Sales of Investments | $0.00B | $0.00B | $0.04B | $0.00B | $0.72B |
| Net Cash from Investing | ($2.76B) | ($4.41B) | ($6.20B) | ($2.08B) | ($7.30B) |
| Financing Activities | |||||
| Common Stock Repurchased | ($5.68B) | ($0.30B) | ($0.59B) | ($0.50B) | ($0.38B) |
| Dividends Paid | ($5.39B) | ($4.70B) | ($4.45B) | ($4.17B) | ($4.01B) |
| Debt Issued / Repaid | $2.07B | ($0.89B) | ($3.14B) | ($1.23B) | ($2.80B) |
| Net Cash from Financing | ($9.26B) | ($5.76B) | ($8.05B) | ($5.82B) | ($7.06B) |
| Free Cash Flow | |||||
| Free Cash Flow | $10.14B | $5.89B | $8.64B | $8.32B | $8.48B |
| FCF Margin %(computed) | 21.71% | 13.29% | 20.76% | 20.52% | 21.64% |
数据来源：Financial Modeling Prep · 最后更新：2026-06-10 · EUR · B
深入了解Sanofi
关于Sanofi（SNY）现金流量表
Sanofi 2025财年经营活动现金流$12.13B，自由现金流$10.14B（FCF利润率21.71%），资本支出($1.99B)。
常见问题
SNY · 4 问Sanofi 2025财年自由现金流$10.14B，同比up72.3%。
SNY free cash flowFCF margincash flow yield
· Source: FMP /stable/cash-flow-statement · SEC EDGAR Form 10-K & 10-Q · As of 2026-06-10